If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2005 Ph.D., Genetics & Complex Diseases, Graduate School of Arts & Sciences, Harvard University
  • 1993 M.D., School of Medicine, Taipei Medical University

Experience

  • 2014.08- Associate Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
  • 2017.02- Attending Physician, Division of Gastroenterology, Department of Medicine, Wan Fang Hospital, Taipei Medical University
  • 2008.08-2014.07 Assistant Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
  • 2007.09-2008.07 Assistant Professor, Department of Internal Medicine, Taipei Medical University

Research Interests

  • Cell and Molecular Biology
  • Cancer Biology
  • Cancer Stem Cells
  • Cancer Molecular Medicine
  • Pancreatic Cancer
  • Breast Cancer
  • Cancer Treatment Resistance

Awards

  • 2018 Outstanding Research Award (Life Science), Ministry of Science and Technology (MOST), Taiwan
  • 2018 The 5th Kobayashi's Foundation Award, Kobayashi Foundation for Cancer Research, Japan
  • 2017 Ta-Cheng Tung's Basic Cancer Research Award, Taiwan Oncology Society
  • 2017 The Breast Journal Award, Wiley-Blackwell, USA
  • 2016 Research Prize, NCKUH, Taiwan
  • 2014 Young Scientist Research Achievement Award, National Health Research Institutes, Taiwan
  • 2014 Research Prize, NCKUH, Taiwan
  • 2012 Merit Award, Asian Clinical Oncology Society (ACOS)
  • 2005 Ruth L. Kirschstein National Research Service Award, National Institutes of Health (NIH), USA
  • 2004 Harvard Presidential Scholar, Harvard University, Cambridge, MA, USA
  • 2004 Glenn/AFAR Scholar, American Federation for Aging Research, USA
  • 2001-2003 Government Scholar, Ministry of Education (MOE), Taiwan
  • 2001 Scholarship of the Ivy Association for Cultural and Educational Exchange, Taiwan
  • 1999 Research Prize, TVGH, Taiwan

Fingerprint Dive into the research topics where Kun-Chih Tsai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Leukocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Membrane Potentials Medicine & Life Sciences
Catenins Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2020

Research Output 1998 2019

  • 1458 Citations
  • 20 h-Index
  • 30 Article
  • 2 Comment/debate
  • 2 Review article
1 Citation (Scopus)

ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling

Pai, V. C., Hsu, C. C., Chan, T. S., Liao, W. Y., Chuu, C. P., Chen, W. Y., Li, C. R., Lin, C. Y., Hwang, S. P., Chen, L. T. & Tsai, K. K., Feb 21 2019, In : Oncogene. 38, 8, p. 1340-1353

Research output: Contribution to journalArticle

Catenins
Microcephaly
Prostatic Neoplasms
Neoplastic Stem Cells
Neoplasms
1 Citation (Scopus)

Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling (Oncogene, (2019), 38, 8, (1340-1353), 10.1038/s41388-018-0497-4)

Pai, V. C., Hsu, C. C., Chan, T. S., Liao, W. Y., Chuu, C. P., Chen, W. Y., Li, C. R., Lin, C. Y., Huang, S. P., Chen, L. T. & Tsai, K. K., Feb 21 2019, In : Oncogene. 38, 8, 1 p.

Research output: Contribution to journalComment/debate

Catenins
Oncogenes
Prostatic Neoplasms
8 Citations (Scopus)
Proton Pump Inhibitors
Hepatocellular Carcinoma
Confidence Intervals
Hepatitis C
Hepatitis B
16 Citations (Scopus)

Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?

André, N., Tsai, K., Carré, M. & Pasquier, E., May 1 2017, In : Trends in Cancer. 3, 5, p. 319-325 7 p.

Research output: Contribution to journalReview article

Drug Therapy
Neoplasms
Immunotherapy
Immune System
Therapeutics
2 Citations (Scopus)

Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma

Chang, K. Y., Huang, C. T., Hsu, T. I., Hsu, C. C., Liu, J. J., Chuang, C. K., Hung, J. J., Chang, W. C., Tsai, K. K. & Chuang, J. Y., Nov 4 2017, In : Biochemical and Biophysical Research Communications. 493, 1, p. 14-19 6 p.

Research output: Contribution to journalArticle

Neoplasm Genes
Glioblastoma
Gene expression
Chemical activation
temozolomide